Randomization-based methods for correcting for treatment changes: examples from the Concorde trial.
about
Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study.Randomised controlled trials and clinical maternity care: moving on from intention-to-treat and other simplistic analyses of efficacy.Adjusting for the Confounding Effects of Treatment Switching-The BREAK-3 Trial: Dabrafenib Versus DacarbazineAdjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy.Gaining power and precision by using model-based weights in the analysis of late stage cancer trials with substantial treatment switching.Adjusting Overall Survival Estimates after Treatment Switching: a Case Study in Metastatic Castration-Resistant Prostate Cancer.A method for the analysis of repeated binary outcomes in randomized clinical trials with non-compliance.Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.A causal model for longitudinal randomised trials with time-dependent non-compliance.A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes.Correcting overall survival for the impact of crossover via a rank-preserving structural failure time (RPSFT) model in the RECORD-1 trial of everolimus in metastatic renal-cell carcinoma.Treatment switching in oncology trials and the acceptability of adjustment methods.On an enhanced rank-preserving structural failure time model to handle treatment switch, crossover, and dropout.Baseline information in structural failure time estimators for the effect of observed treatment compliance.Correcting treatment effect for treatment switching in randomized oncology trials with a modified iterative parametric estimation method.Adjusting for treatment switching in randomised controlled trials - A simulation study and a simplified two-stage method.rpsftm: An R Package for Rank Preserving Structural Failure Time Models.Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context
P2860
Q33790415-BCC71CB0-5054-4EB5-A3FF-E23D5C0FA480Q34550045-B4259633-EA62-42DF-89D0-6E589E8D6A7CQ35820520-3B9B63B8-2523-4E2C-8B04-93C4AE8B7C3DQ36895055-2014EF6E-927C-4854-B5C2-D446CA396E3CQ36912430-A934591C-8534-41BA-A2F5-5EE34FA7AB4AQ37597690-9853C3DF-0640-4B02-B6B8-276641E05E76Q40597384-92209433-D017-45AA-B217-751A0833A4EEQ41103027-1A4FF623-A27E-4D90-8C17-20B1584D0797Q41207172-00C1D12A-43BA-4CE2-AC51-D7B86EFC153DQ42627798-221C601C-9CF0-45D1-AA19-34C6965B5ADBQ44365759-2390FBEA-5461-4EB9-A19B-6867C3200309Q48040468-FF28F498-2CBC-4E20-AF89-7E2725E011CEQ48326642-2074DDE7-CA23-4BB5-9F58-0EE38E4880DDQ49044408-1DB3FB5F-A781-455D-BEA1-9962C6283302Q50703919-6CA76FD6-4007-4887-8C60-41384C32DECFQ51008987-F1A5E2DF-0687-4D58-827B-8F1BAC75A8F5Q53276112-BEF6AFF9-C8A5-4C03-9464-61AE3DB9D749Q57493510-16A9B7DB-7487-4C4A-B893-0208879542F4
P2860
Randomization-based methods for correcting for treatment changes: examples from the Concorde trial.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Randomization-based methods fo ...... mples from the Concorde trial.
@en
Randomization-based methods fo ...... mples from the Concorde trial.
@nl
type
label
Randomization-based methods fo ...... mples from the Concorde trial.
@en
Randomization-based methods fo ...... mples from the Concorde trial.
@nl
prefLabel
Randomization-based methods fo ...... mples from the Concorde trial.
@en
Randomization-based methods fo ...... mples from the Concorde trial.
@nl
P2093
P2860
P1476
Randomization-based methods fo ...... mples from the Concorde trial.
@en
P2093
Babiker AG
Darbyshire JH
P2860
P304
P356
10.1002/(SICI)1097-0258(19991015)18:19<2617::AID-SIM187>3.0.CO;2-E
P407
P577
1999-10-01T00:00:00Z